XML 51 R39.htm IDEA: XBRL DOCUMENT v3.20.4
Note 16 - Segment Reporting (Tables)
6 Months Ended
Dec. 31, 2020
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   
Three months Ended December 31,
   
Six Months Ended December 31,
 
   
2020
   
2019
   
2020
   
2019
 
Consolidated revenue:
                               
Aytu BioScience
  $
7,212,000
    $
3,175,000
    $
13,000,000
    $
4,615,000
 
Aytu Consumer Health
   
7,935,000
     
-
     
16,000,000
     
-
 
Consolidated revenue
   
15,147,000
     
3,175,000
     
29,000,000
     
4,615,000
 
                                 
Consolidated net loss:
                               
Aytu BioScience
   
(8,267,000
)    
(214,000
)    
(11,218,000
)    
(5,143,000
)
Aytu Consumer Health
   
(1,258,000
)    
-
     
(2,613,000
)    
-
 
Consolidated net loss
   
(9,525,000
)    
(214,000
)    
(13,831,000
)    
(5,143,000
)
   
As of
   
As of
 
   
December 31,
   
June 30,
 
   
2020
   
2020
 
Total assets:
               
Aytu BioScience
  $
140,647,000
    $
126,267,000
 
Aytu Consumer Health
   
26,095,000
     
26,569,000
 
Total assets
  $
166,742,000
    $
152,836,000